nach oben

Erschienen in:

12.04.2018 | Neuro

Remote brain microhaemorrhages may predict haematoma in glioma patients treated with radiation therapy

verfasst von: Augustin Lecler, Frédérique Charbonneau, Dimitri Psimaras, Marie-Astrid Metten, Antoine Gueguen, Khe Hoang Xuan, Loic Feuvret, Julien Savatovsky

Erschienen in: European Radiology | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the prevalence of cerebral remote microhaemorrhages (RMH) and remote haematomas (RH) using magnetic resonance susceptibility-weighted imaging (SWI) among patients treated for gliomas during follow-up.

Methods

We conducted a retrospective single centre longitudinal study on 58 consecutive patients treated for gliomas from January 2009 through December 2010. Our institutional review board approved this study. We evaluated the presence and number of RMH and RH found outside the brain tumour on follow-up MR imaging. We performed univariate and bivariate analyses to identify predictors for RMH and RH and Kaplan–Meier survival analysis techniques.

Results

Twenty-five (43%) and four patients (7%) developed at least one RMH or RH, respectively, during follow-up. The risk was significantly higher for patients who received radiation therapy (49% and 8% versus 0%) (p = 0.02). The risk of developing RH was significantly higher in patients with at least one RMH and a high burden of RMH. The mean age of those presenting with at least one RMH or RH was significantly lower.

Conclusions

RMH were common in adult survivors of gliomas who received radiation therapy and may predict the onset of RH during follow-up, mainly in younger patients.

Key Points

• Brain RMH and RH are significantly more likely to occur after RT.

• RMH occur in almost half of the patients treated with RT.

• RMH and RH are significantly more frequent in younger patients.

• RH occur only in patients with RMH.

Nur mit Berechtigung zugänglich

Shinohara C, Muragaki Y, Maruyama T et al (2008) Long-term prognostic assessment of 185 newly diagnosed gliomas: grade III glioma showed prognosis comparable to that of Grade II glioma. Jpn J Clin Oncol 38:730–733CrossRef

Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996CrossRef

Douw L, Klein M, Fagel SS et al (2009) Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol 8:810–8182CrossRef

Peters S, Pahl R, Claviez A, Jansen O (2013) Detection of irreversible changes in susceptibility-weighted images after whole-brain irradiation of children. Neuroradiology 55:853–859CrossRef

Lupo JM, Chuang CF, Chang SM et al (2012) 7-Tesla susceptibility-weighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma. Int J Radiat Oncol Biol Phys 82:e493–e500CrossRef

Jain R, Robertson PL, Gandhi D et al (2005) Radiation-induced cavernomas of the brain. AJNR Am J Neuroradiol 26:1158–1162PubMed

Bian W, Hess CP, Chang SM et al (2014) Susceptibility-weighted MR imaging of radiation therapy-induced cerebral microbleeds in patients with glioma: a comparison between 3T and 7T. Neuroradiology 56:91–96CrossRef

Zeng Q-S, Kang X-S, Li C-F, Zhou G-Y (2011) Detection of hemorrhagic hypointense foci in radiation injury region using susceptibility-weighted imaging. Acta Radiol 52:115–119CrossRef

Lupo JM, Molinaro AM, Essock-Burns E et al (2016) The effects of anti-angiogenic therapy on the formation of radiation-induced microbleeds in normal brain tissue of patients with glioma. Neuro Oncol 18:87–95CrossRef

10.

Walker MD, Alexander E, Hunt WE et al (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49:333–343PubMed

11.

Valk PE, Dillon WP (1991) Radiation injury of the brain. AJNR Am J Neuroradiol 12:45–62PubMed

12.

Roddy E, Sear K, Felton E et al (2016) Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivors. Neuro-Oncol 18:1548–1558CrossRef

13.

Charidimou A, Werring DJ (2012) Cerebral microbleeds and cognition in cerebrovascular disease: an update. J Neurol Sci 322:50–55CrossRef

14.

Valenti R, Del Bene A, Poggesi A et al (2016) Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study. J Neurol Sci 368:195–202CrossRef

15.

Ayaz M, Boikov AS, Haacke EM et al (2010) Imaging cerebral microbleeds using susceptibility weighted imaging: one step toward detecting vascular dementia. J Magn Reson Imaging JMRI 31:142–148CrossRef

16.

Werring DJ, Gregoire SM, Cipolotti L (2010) Cerebral microbleeds and vascular cognitive impairment. J Neurol Sci 299:131–135CrossRef

17.

Landis JR, Koch GG (1977) An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 33:363–374CrossRef

18.

Core Team R (2014) R: A language and environment for statistical computing. In: R Foundation for Statistical Computing, Vienna http://www.R-project.org/. Accessed date: 2014

19.

Reinhold HS, Hopewell JW (1980) Late changes in the architecture of blood vessels of the rat brain after irradiation. Br J Radiol 53:693–696CrossRef

20.

Cutsforth-Gregory JK, Lanzino G, Link MJ et al (2015) Characterization of radiation-induced cavernous malformations and comparison with a nonradiation cavernous malformation cohort. J Neurosurg 122:1214–1222CrossRef

21.

Smart D (2017) Radiation toxicity in the central nervous system: mechanisms and strategies for injury reduction. Semin Radiat Oncol 27:332–339CrossRef

22.

Vinchon M, Leblond P, Caron S et al (2011) Radiation-induced tumors in children irradiated for brain tumor: a longitudinal study. Childs Nerv Syst 27:445–453CrossRef

23.

Mirimanoff R-O, Gorlia T, Mason W et al (2006) Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol 24:2563–2569CrossRef

24.

Cairncross G, Wang M, Shaw E et al (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 31:337–343CrossRef

25.

Ducray F, Idbaih A (2013) Neuro-oncology: anaplastic oligodendrogliomas-value of early chemotherapy. Nat Rev Neurol 9:7–8CrossRef

26.

Jastaniyah N, Murtha A, Pervez N et al (2013) Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme. Radiat Oncol Lond Engl 8:38CrossRef

27.

Combs SE (2017) Does proton therapy have a future in CNS tumors? Curr Treat Options Neurol 19:12CrossRef

28.

Floyd NS, Woo SY, Teh BS et al (2004) Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys 58:721–726CrossRef

29.

Chen Y-D, Feng J, Fang T et al (2013) Effect of intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy on clinical outcomes in patients with glioblastoma multiforme. Chin Med J (Engl) 126:2320–2324

30.

Zach L, Stall B, Ning H et al (2009) A dosimetric comparison of four treatment planning methods for high grade glioma. Radiat Oncol Lond Engl 4:45CrossRef

31.

Letarte N, Bressler LR, Villano JL (2013) Bevacizumab and central nervous system (CNS) hemorrhage. Cancer Chemother Pharmacol 71:1561–1565CrossRef

32.

Zuo P-Y, Chen X-L, Liu Y-W et al (2014) Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis. PLoS One 9:e102484CrossRef

33.

Hapani S, Sher A, Chu D, Wu S (2010) Increased risk of serious hemorrhage with bevacizumab in cancer patients: a meta-analysis. Oncology 79:27–38CrossRef

34.

Kamba T, McDonald DM (2007) Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer 96:1788–1795CrossRef

35.

de Souza JM, Domingues RC, Cruz LCH et al (2008) Susceptibility-weighted imaging for the evaluation of patients with familial cerebral cavernous malformations: a comparison with t2-weighted fast spin-echo and gradient-echo sequences. AJNR Am J Neuroradiol 29:154–158CrossRef

36.

de Champfleur NM, Langlois C, Ankenbrandt WJ et al (2011) Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery 68:641–647 discussion 647-648CrossRef

37.

Bian W, Banerjee S, Kelly DAC et al (2015) Simultaneous imaging of radiation-induced cerebral microbleeds, arteries and veins, using a multiple gradient echo sequence at 7 Tesla. J Magn Reson Imaging JMRI 42:269–279CrossRef

38.

Jeerakathil T, Wolf PA, Beiser A et al (2004) Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke 35:1831–1835CrossRef

39.

Tsushima Y, Tanizaki Y, Aoki J, Endo K (2002) MR detection of microhemorrhages in neurologically healthy adults. Neuroradiology 44:31–36CrossRef

Titel: Remote brain microhaemorrhages may predict haematoma in glioma patients treated with radiation therapy
verfasst von: Augustin Lecler
Frédérique Charbonneau
Dimitri Psimaras
Marie-Astrid Metten
Antoine Gueguen
Khe Hoang Xuan
Loic Feuvret
Julien Savatovsky
Publikationsdatum: 12.04.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Radiology / Ausgabe 10/2018
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-018-5356-8

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Remote brain microhaemorrhages may predict haematoma in glioma patients treated with radiation therapy